American Century Companies

AMERICAN CENTURY INVESTMENTS® RELEASES FINDINGS FROM WOMEN AND FINANCE SURVEY

Retrieved on: 
Monday, December 12, 2022
Asset, American Century Companies, National Women's Media Centre, Woman, Female, Stowers Institute for Medical Research, Century, Federal Deposit Insurance Corporation, Research, Accounting, National Women's Soccer League, IRA, American Century, Investment, Medical research, Birth control, Pension fund

The $210 billon* global asset manger recently released findings from its Women + Finance Survey.

Key Points: 
  • The $210 billon* global asset manger recently released findings from its Women + Finance Survey.
  • The full Women + Finance Survey, which includes additional findings, is separated by age.
  • American Century Investments is a leading global asset manager focused on delivering investment results and building long-term client relationships while supporting breakthrough medical research.
  • The Institute owns more than 40% of American Century Investments and has received dividend payments of $1.87 billion since 2000.

AMERICAN CENTURY INVESTMENTS LEVERAGES SAPHYRE'S PATENTED AI PLATFORM FOR THE ONBOARDING AND MAINTENANCE OF FUNDS ACROSS BROKERS AND CUSTODIANS

Retrieved on: 
Wednesday, November 2, 2022
Medical research, Investment, Growth, American Century Companies, Stowers Institute for Medical Research, Industry, Risk, Institute, American Century, AI, View, Memory, Maintenance, Technology, Multimedia, Security (finance), Financial services

American Century consulted Saphyre about providing a seamless streamlined process for new funds with asset owners, and to maintain reliable and specific permissioned information to their counterparties on existing funds.

Key Points: 
  • American Century consulted Saphyre about providing a seamless streamlined process for new funds with asset owners, and to maintain reliable and specific permissioned information to their counterparties on existing funds.
  • The Saphyre platform significantly reduces the time to set-up a new fund, while also providing all updated data related to the fund.
  • American Century Investments is a leading global asset manager focused on delivering investment results and building long-term client relationships while supporting breakthrough medical research.
  • The Institute owns more than 40% of American Century Investments and has received dividend payments of $1.87 billion since 2000.

Discovery of 119-million-year-old selfish genes in yeast potentially alters our understanding of how parasitic DNA impacts genome evolution

Retrieved on: 
Wednesday, October 19, 2022
National Institute, American Century Companies, Stowers Institute for Medical Research, Biology, Doctor of Philosophy, Thought, Technology, Life, Population, Medical research, Association, Longevity, Perception, NIH, Institute, Multimedia, New, Mutation, Health, National, Spore, Egg, Meiosis, National Institutes of Health Office of Science Policy, Infertility, Genome, Fertility, Cell division, Chromosome, Gene, Human, Agriculture, Pharmaceutical industry, Antibiotics, Science, ELife

Meiotic drivers are thus named as they can acquire the ability to literally "drive" the transmission of their genes throughout a genome, often with negative consequences.

Key Points: 
  • Meiotic drivers are thus named as they can acquire the ability to literally "drive" the transmission of their genes throughout a genome, often with negative consequences.
  • Natural selection in a genome typically rescues a species from selfish genes by favoring genes that suppress, or silence drive, rendering it useless.
  • It also changes the way scientists may look for and identify families of selfish genes in different species, including humans.
  • "Since selfish genes are major drivers of evolution, this new finding opens the door for thinking about how drivers can have persistent, long-term effects on genome evolution."

SHORT DURATION STRATEGIC INCOME ETF LAUNCHED BY AMERICAN CENTURY

Retrieved on: 
Thursday, October 13, 2022
American Century Companies, Stowers Institute for Medical Research, SDSI, Investment, Exchange-traded fund, Medical research, NASDAQ, Income, Multimedia, Institute, Philosophy, ETF, Lovell Minnick Partners, NAV, Asset, View, Financial adviser, Security (finance), Life insurance, Bank, American Century

Now listed on NASDAQ, American Century Short Duration Strategic Income (SDSI) is the latest addition to the firm's active ETF lineup .

Key Points: 
  • Now listed on NASDAQ, American Century Short Duration Strategic Income (SDSI) is the latest addition to the firm's active ETF lineup .
  • "SDSI expands our existing Short Duration Strategic Income capabilities to an actively managed ETF," said Ed Rosenberg , American Century's head of ETFs.
  • "The Short Duration Strategic Income ETF seeks to complement an investor's core bond holdings with high current income, broad diversification and the potential to mitigate the impact of rising rates."
  • Exchange Traded Funds (ETFs): Foreside Fund Services, LLC Distributor, not affiliated with American Century Investment Services, Inc.
    2022 American Century Proprietary Holdings, Inc. All rights reserved.

AVANTIS REACHES THREE-YEAR ANNIVERSARY, CONTINUES TO EXPAND OFFERING

Retrieved on: 
Thursday, September 29, 2022
Institute, Time, Stowers Institute for Medical Research, American Century, NAV, Health, Investment, Industry, Mining, ETF, American Century Companies, Lovell Minnick Partners, Exchange-traded fund, Medical research, Prospectus, Metal, Asset, Bank, Security (finance)

Jonathan S. Thomas is president and chief executive officer, and Victor Zhang serves as chief investment officer.

Key Points: 
  • Jonathan S. Thomas is president and chief executive officer, and Victor Zhang serves as chief investment officer.
  • The Institute owns more than 40% of American Century Investments and has received dividend payments of $1.87 billion since 2000.
  • Exchange Traded Funds (ETFs) are bought and sold through exchange trading at market price (not NAV) and are not individually redeemed from the fund.
  • Exchange Traded Funds (ETFs): Foreside Fund Services, LLC Distributor, not affiliated with American Century Investment Services, Inc.
    2022 American Century Proprietary Holdings, Inc. All rights reserved.

"INCOME BLUEPRINT" FOR RETIREMENT PLAN FIDUCIARIES LAUNCHES

Retrieved on: 
Tuesday, September 20, 2022
Institute, Act, Stowers Institute for Medical Research, Baby boomers, 2020 United States federal budget, Investment, Industry, Project for the New American Century, American Century Companies, Medical research, Documentation, Retirement, Multimedia, View, JD, Life insurance, Financial adviser, Online shopping, American Century, Income

KANSAS CITY, Mo., Sept. 20, 2022 /PRNewswire/ -- American Century Investments® has launched Income Blueprint, a first-of-its-kind online tool to help retirement plan fiduciaries implement a prudent process to evaluate and choose in-plan guaranteed income products for their clients in line with the recently passed SECURE Act's guidance. The Income Blueprint tool simplifies the complex world of available products and generates a customizable report that compares and scores each one according to plan preferences.

Key Points: 
  • The Income Blueprint tool simplifies the complex world of available products and generates a customizable report that compares and scores each one according to plan preferences.
  • The Income Blueprint comes at a time of high interest from plan participants, combined with a safe harbor and portability provisions included in the SECURE Act, according to Glenn Dial, American Century senior retirement strategist.
  • "Overall, interest is high, with 76% of respondents in our 2021 retirement survey showing interest in investment options specifically designed to help them draw income from their plan savings during retirement."
  • "As rising demand and high interest lead more retirement fiduciaries to consider in-plan retirement income options, they need clarity to make the best selections and confidence that they've fulfilled industry regulations and maintained their safe harbor," added Rick Luchinsky, American Century's co-head of Intermediary Distribution.

Logan Capital Management Adds Portfolio Manager

Retrieved on: 
Tuesday, September 20, 2022
Consulting, Professional Services, Finance, Principal, Growth, Investment, Philosophy, Boeing, Portfolio manager, Business, History, RIA, Oaktree Capital Management, Research, American Century Companies, CFA, Financial services, Public relations

Logan Capital Management, Inc. (Logan Capital), a registered investment advisor with a series of separately managed accounts in equity and fixed-income strategies, has hired Dan Gruemmer, CFA, as Managing Director and Portfolio Manager.

Key Points: 
  • Logan Capital Management, Inc. (Logan Capital), a registered investment advisor with a series of separately managed accounts in equity and fixed-income strategies, has hired Dan Gruemmer, CFA, as Managing Director and Portfolio Manager.
  • Most recently, he worked at American Century Investments as a Portfolio Manager of the equity income fund and market neutral value fund.
  • Logan Capital Management, Inc. (Logan Capital) is an employee-owned registered investment advisor (RIA) headquartered in Newtown Square, Pennsylvania.
  • Logan Capital Management has a sustained history of working closely with financial advisors and their clients.

Stowers scientists use zebrafish to understand the connection between the immune system and regeneration

Retrieved on: 
Tuesday, September 20, 2022
Institute, Macrophage, Enzyme, Zebrafish, Inflammation, Deafness, Human, Cytokine, Spinal cord, National, Stowers Institute for Medical Research, Brain, Hearing loss, Population, Life, Regeneration, Synapse, Language, Communication, Injury, Cell, Medical research, Bacteria, Doctor of Philosophy, Nature Communications, Tissue, Stowers, Heart, American Century Companies, Multimedia, Immune system, NIH, National Institute, Silviculture, Pharmaceutical industry

KANSAS CITY, Mo., Sept. 20, 2022 /PRNewswire/ -- How the immune system responds to injury in many organs and tissues allows and enables their repair and regeneration.

Key Points: 
  • KANSAS CITY, Mo., Sept. 20, 2022 /PRNewswire/ -- How the immune system responds to injury in many organs and tissues allows and enables their repair and regeneration.
  • New research from the Stowers Institute for Medical Research used the highly regenerative zebrafish to investigate the timing and genetic programs of macrophages, a type of white blood cell, in the repair and regeneration of a zebrafish sensory organ.
  • "Identifying the molecular recipe of macrophage activation in zebrafish may one day enable us to design regenerative immunotherapies in humans."
  • Investigating macrophages at high spatial resolution and at multiple closely spaced time points during zebrafish sensory hair cell death and regeneration was critical.

AMERICAN CENTURY INVESTMENTS' DAVID LIVINGSTON RECEIVES NICSA RISING STAR AWARD

Retrieved on: 
Monday, September 19, 2022
Institute, LGBTQ, Pride, FINRA, Stowers Institute for Medical Research, American Century, University of Missouri–Kansas City School of Law, Association, Century, Compliance, Investment, BRG, American Century Companies, Industry, Environment, Series 6, Medical research, Friends, Workplace, AIDS Walk, Awareness, Multimedia, University, NICSA, View, Management

KANSAS CITY, Mo., Sept. 19, 2022 /PRNewswire/ -- American Century Investments Director of Compliance David Livingston was recognized as a Rising Star by the National Investment Company Service Association (Nicsa).

Key Points: 
  • KANSAS CITY, Mo., Sept. 19, 2022 /PRNewswire/ -- American Century Investments Director of Compliance David Livingston was recognized as a Rising Star by the National Investment Company Service Association (Nicsa).
  • Livingston, who has been with American Century since 2011, plays an active role in American Century's Pride Business Resource Group (BRG).
  • "I'm honored to represent American Century Investments as a Diversity Project North America 2022 Rising Star," said Livingston.
  • Livingston joined American Century Investments in 2011 as a senior marketing compliance consultant and has served as director of compliance since February 2019.

BioMed Valley Discoveries Announces First Patient Dosed in Phase II Combination Trial with Ulixertinib (BVD-523), its First-in-Class and Best-in-Class ERK Inhibitor, in Combination with Hydroxychloroquine

Retrieved on: 
Monday, September 12, 2022
Institute, Stowers Institute for Medical Research, MAPK, Autophagy, Phase, American Century, Neoplasm, Century, University, Investment, BRAF, Hydroxychloroquine, ERK2, Survival, ERK, Patient, Clinical trial, BVD, Huntsman Cancer Institute, Medical research, Tumor microenvironment, HCQ, ERK1, American Century Companies, Mutation, Pharmaceutical industry

KANSAS CITY, Mo., Sept. 12, 2022 /PRNewswire/ -- BioMed Valley Discoveries (BVD) announced that the first patient has been dosed in a phase II clinical trial of ulixertinib (BVD-523) in combination with hydroxychloroquine (HCQ).

Key Points: 
  • KANSAS CITY, Mo., Sept. 12, 2022 /PRNewswire/ -- BioMed Valley Discoveries (BVD) announced that the first patient has been dosed in a phase II clinical trial of ulixertinib (BVD-523) in combination with hydroxychloroquine (HCQ).
  • Ulixertinib is a first-in-class and best-in-class ERK inhibitor, with this clinical trial focusing on patients with advanced gastrointestinal malignancies and mutations in the MAPK pathway.
  • Previous efforts have also established a recommended phase 2 dose in combination with palbociclib, with additional combination efforts ongoing.
  • About BioMed Valley Discoveries (BVD): BioMed Valley Discoveries is a clinical stage biotechnology company focused on addressing unmet medical needs in a variety of therapeutic and diagnostic areas.